0001104659-18-071882.txt : 20181207
0001104659-18-071882.hdr.sgml : 20181207
20181207180541
ACCESSION NUMBER: 0001104659-18-071882
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181204
FILED AS OF DATE: 20181207
DATE AS OF CHANGE: 20181207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McLaughlin Gerald W.
CENTRAL INDEX KEY: 0001495412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37508
FILM NUMBER: 181224496
MAIL ADDRESS:
STREET 1: 227 WASHINGTON STREET
STREET 2: SUITE 200
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001467652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270395455
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
BUSINESS PHONE: 972.408.1360
MAIL ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
4
1
a4.xml
4
X0306
4
2018-12-04
0
0001467652
Neos Therapeutics, Inc.
NEOS
0001495412
McLaughlin Gerald W.
C/O NEOS THERAPEUTICS, INC.
2940 N. HWY 360
GRAND PRAIRIE
TX
75050
1
1
0
0
Chief Executive Officer
Common Stock
2018-12-04
4
P
0
7403
2.0424
A
7403
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $2.01 to $2.06, inclusive. The reporting person undertakes to provide Neos Therapeutics, Inc., any security holder of Neos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
/s/ Richard Eisenstadt, attorney in fact
2018-12-07